About
The Winslow philosophy
Company background
Our associates
Careers at Winslow
News
Commentary library
Philanthropy at Winslow
Spotlight on Winslow
Contact
Contact us
Contact associates
Directions – Boston
Directions – Braintree, MA
Directions – New York City
Directions – Paramus, NJ
Account Login
Account Resources
Cybersecurity
Tax Form Downloads to TurboTax®
Important information for investors
INDIVIDUAL INVESTORS
+ What approach is right for me?
+ Choosing a financial professional
+ Brokers
+ Investment advisors
+ The Winslow philosophy
+ Plan for life
+ What to expect: Six steps
+ Plan for retirement
+ Save for college
+ Invest and trade
+ Tax-advantaged investing
+ Trading desk services
+ Client support
+ Insure your future
+ Life insurance
+ Annuities: “Income for life”
+ Property and casualty
+ Submit your current policy
+ Long-term care
INSTITUTIONAL INVESTORS
+ Equity trading
+ Fixed income
+ Municipal desk
FIND AN ADVISOR
+ by Name
+ by Branch
OPPORTUNITIES AT WINSLOW
+ Financial advisors
+ Business partners
+ Working with Winslow
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Medpace Holdings Inc
(NQ:
MEDP
)
138.45
-1.55 (-1.11%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 17, 2022
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Medpace Holdings Inc
< Previous
1
2
Next >
Medpace Posts Better Than Expected Q1 Earnings, Lifts FYY22 Profit Outlook
April 26, 2022
Via
Benzinga
Earnings Scheduled For April 25, 2022
April 25, 2022
Companies Reporting Before The Bell • Arrival (NASDAQ:ARVL) is expected to report earnings for its fourth quarter.
Via
Benzinga
Medpace Reports Mixed Q4 Earnings, Issues FY22 Guidance Ahead Of Estimates
February 15, 2022
Medpace Holdings Inc's (NASDAQ: MEDP)
Via
Benzinga
Recap: Medpace Hldgs Q4 Earnings
February 14, 2022
Medpace Hldgs (NASDAQ:MEDP) reported its Q4 earnings results on Monday, February 14, 2022 at 04:15 PM. Here's what investors need to know about the announcement.
Via
Benzinga
Earnings Preview: Medpace Hldgs
April 22, 2022
Medpace Hldgs (NASDAQ:MEDP) is set to give its latest quarterly earnings report on Monday, 2022-04-25. Here's what investors need to know before the announcement. Analysts estimate that Medpace Hldgs...
Via
Benzinga
55 Biggest Movers From Yesterday
February 16, 2022
Check this out: Insiders Buy Around $112M Of 3 Stocks. Losers Larimar Therapeutics, Inc. (NASDAQ: LRMR) shares fell 52.1% to close at $4.01 on Tuesday after the company...
Via
Benzinga
Mid-Afternoon Market Update: Dow Jumps 400 Points; Marriott International Tops Q4 Views
February 15, 2022
US stocks remained higher toward the end of trading session on Tuesday after Russia announced it would pull back some troops positioned on the Ukrainian border.
Via
Benzinga
Stocks Rebound as Geopolitical Tensions Ease
February 15, 2022
All three major indexes are looking to snap three-day losing streaks.
Via
Talk Markets
Mid-Day Market Update: Crude Oil Down 4%; US Producer Prices Rise 1% In January
February 15, 2022
US stocks remained higher midway through trading on Tuesday after Russia announced it would pull back some troops positioned on the Ukrainian border.
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
February 15, 2022
Tuesday's session saw 95 companies set new 52-week lows. Noteworthy Highlights From Today's 52-Week Lows: The largest company by market cap to set a new 52-...
Via
Benzinga
31 Stocks Moving In Tuesday's Mid-Day Session
February 15, 2022
Gainers Resonant Inc. (NASDAQ: RESN) jumped 249% to $4.29 after Murata Electronics announced plans to buy the company at $4.50 per share in cash. Tower Semiconductor Ltd. (NASDAQ...
Via
Benzinga
Mid-Morning Market Update: Markets Open Higher On Easing Russia-Ukraine Tensions
February 15, 2022
US stocks opened on a strong note this morning after Russia announced it would pull back some troops positioned on the Ukrainian border.
Via
Benzinga
The Week Ahead In Biotech (Feb. 13-19): Agios FDA Meeting, Avenue Adcom, Earnings And More
February 13, 2022
Biotech stocks moved back and forth amid some volatility before finishing the week ending Feb. 11 modestly lower, reversing the gains from the previous week. Earnings news...
Via
Benzinga
Earnings Scheduled For February 14, 2022
February 14, 2022
Companies Reporting Before The Bell • Weber (NYSE:WEBR) is projected to report quarterly loss at $0.06 per share on revenue of $310.78 million.
Via
Benzinga
Earnings Preview For Medpace Hldgs
February 11, 2022
Medpace Hldgs (NASDAQ:MEDP) is set to give its latest quarterly earnings report on Monday, 2022-02-14. Here's what investors need to know before the announcement. Analysts estimate that Medpace Hldgs...
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
January 31, 2022
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...
Via
Benzinga
5 Stocks Insiders Are Selling
December 31, 2021
When insiders sell shares, it indicates their concern in the company’s prospects or that they view the stock as being overpriced. Either way, this signals an opportunity to...
Via
Benzinga
This Diversified Healthcare Stock Offers Explosive Biotech-Like Growth
November 15, 2021
Since its IPO five years ago, this clinical trial specialist is up over 700%.
Via
The Motley Fool
Topics
Initial Public Offering
Exposures
Securities Market
PerkinElmer Stock, Already Highly Rated, Perks Up Further Amid Brisk Sales, Profit Growth For Its Instruments
November 11, 2021
A Relative Strength Rating upgrade for PerkinElmer shows improving technical performance. Will it continue?
Via
Investor's Business Daily
Exposures
COVID-19
Thermo Fisher Stock Strength Rating Climbs To 81; Medical Devices Maker Shows Market Leadership
October 28, 2021
Thermo Fisher Scientific shows improving price performance, earning an upgrade to its IBD Relative Strength Rating from 77 to 81.
Via
Investor's Business Daily
60 Biggest Movers From Yesterday
October 27, 2021
Gainers Inspira Technologies Oxy B.H.N. Ltd. (NASDAQ: IINN) shares surged 308.1% to settle at $9.59 on Tuesday after the company signed an agreement with Waas Group for the...
Via
Benzinga
Medpace Holdings, Inc. Common Stock (MEDP) Q3 2021 Earnings Call Transcript
October 27, 2021
MEDP earnings call for the period ending September 30, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
12 Health Care Stocks Moving In Tuesday's Intraday Session
October 26, 2021
Gainers Ocugen (NASDAQ:OCGN) shares increased by 26.44% to $11.81 during Tuesday's regular session. Trading volume for this security as of 12:30 EST is 135.6 million,...
Via
Benzinga
40 Stocks Moving In Tuesday's Mid-Day Session
October 26, 2021
Gainers Wallbox N.V. (NYSE: WBX) shares climbed 54.5% to $17.16. Uber and Wallbox N.V. disclosed a strategic partnership to simplify the transition to EVs for Bay Area ride...
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
October 25, 2021
Gainers Medpace Hldgs (NASDAQ:MEDP) shar...
Via
Benzinga
Earnings Scheduled For October 25, 2021
October 25, 2021
Companies Reporting Before The Bell • HNI (NYSE:HNI) is expected to report quarterly earnings at $0.43 per share on revenue of $592.14 million. • Travelzoo (...
Via
Benzinga
Earnings Outlook For Medpace Hldgs
October 22, 2021
Medpace Hldgs (NASDAQ:MEDP) is set to give its latest quarterly earnings report on Monday, 2021-10-25. Here's what investors need to know before the announcement. Analysts...
Via
Benzinga
Medpace Hldgs Insider Trades $12 Million In Company Stock
September 08, 2021
Susan E Burwig, Exec. Vp And Operations at Medpace Hldgs (NASDAQ:MEDP), made a large insider sell on September 3, according to a new SEC filing. What Happened: A Form 4 filing...
Via
Benzinga
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
The Daily Biotech Pulse: MacroGenics' Clinical Trial Disappointment, Sanofi to Buy Kadmon, Alector Loses 2 Key Executives, ADMA's FDA Nod
September 08, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 7) Adial Pharmaceuticals, Inc...
Via
Benzinga
Exposures
Product Safety
Medpace Stock Earns Relative Strength Rating Upgrade; Remains In Buy Zone
September 02, 2021
Ohio-based Medpace stock saw its Relative Strength Rating enter the 80-plus level while it stays in a buy zone.
Via
Investor's Business Daily
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Market Action
Symbol Lookup
MARKET NEWS